Stocks
Black Diamond Therapeutics (BDTX) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -22.9 | -67.3 | -125.6 | -95.1 | -86.0 | -84.9 | ||
| Changes by years, y/y, % | +159% | +193% | +87% | -24% | -10% | +57.5% | |||
Black Diamond Therapeutics. EBITDA US GAAP, bln rub
Black Diamond Therapeutics. EBITDA US GAAP, changes, %
Black Diamond Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Black Diamond Therapeutics (BDTX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -21.6 | -19.9 | -24.0 | -20.8 | -20.2 | -84.9 | |
| Changes by years, y/y, % | -16% | -14% | +9% | -14% | -6% | |||
| Changes by quarters, q/q, % | -10% | -8% | +21% | -14% | -3% | |||
